Angiotensin 2 Type 1 Receptor Blockade with Neprilysin Inhibition for Chronic Heart Failure: A New Paradigm?
- Author:
Arthur Mark RICHARDS
1
Author Information
1. Cardiovascular Research Institute, National University Health System, Singapore.
- Publication Type:Editorial
- MeSH:
Angiotensin II Type 1 Receptor Blockers;
pharmacology;
Cardiovascular Agents;
pharmacology;
Clinical Trials as Topic;
Heart Failure;
drug therapy;
Humans;
Neprilysin;
antagonists & inhibitors
- From:Annals of the Academy of Medicine, Singapore
2015;44(8):272-273
- CountrySingapore
- Language:English
